NCT00629512View on ClinicalTrials.gov

Prevention of Gastric Ulcers

PHASE3CompletedINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

NSAID Associated Gastric Ulcers

Interventions

DRUG

Esomeprazole

20mg oral daily

DRUG

Esomeprazole

40mg oral daily

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY